Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Science
Biotechnology
Research
Pharmaceutical
Health
Artificial Intelligence
Technology
Clinical Trials
AACR 2024 Preclinical Translational Oncology research Life Sciences

More Like This

Business Wire logo

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies

Business Wire logo

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

Crown Bioscience and NEXT Oncology Cement Partnership Extension

Business Wire logo

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Business Wire logo

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

Business Wire logo

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us